Ipamorelin (5mg)
Specifiche tecniche
| Purezza (HPLC) | ≥99% (HPLC) |
| Numero CAS | 170851-70-4 |
| Forma | White lyophilized powder |
| Conservazione | -20°C |
| Sequenza | Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
| Peso molecolare | 711.85 g/mol |
| Forma salina | Acetate |
| Solubilità | Soluble in water |
Ipamorelin (5mg)
Prezzo di listino EUR · HU, SK, CZ, PL
- Eurozone (EUR)45,00 EUR
- Ungheria (HU)45,00 EUR≈ 18 000 Ft
- Slovacchia (SK)45,00 EUR
- Cechia (CZ)45,00 EUR≈ 1 125 Kč
- Polonia (PL)45,00 EUR≈ 191,25 zł
Stesso prezzo di listino in EUR per consegna in Ungheria, Slovacchia, Repubblica Ceca e Polonia. Pagamento in EUR.
HUF/CZK/PLN indicativi convertiti da EUR; la Slovacchia usa EUR. Tassi approssimativi. Pagamento in EUR.
Growth hormone secretagogue. For laboratory research use only.
Solo per ricerca di laboratorio.
Non destinato al consumo umano, uso veterinario o diagnostico.
From the Peptide Explorer
A selective growth hormone secretagogue that stimulates GH release via the ghrelin/GHSR-1a receptor without significantly affecting cortisol, ACTH, or prolactin levels. This selectivity distinguishes it from other GHRPs like GHRP-6 and hexarelin.
Key Mechanisms
- ›GHSR-1a (ghrelin receptor) agonism
- ›Selective GH pulse amplification
- ›Minimal cortisol/prolactin elevation
- ›No appetite stimulation (unlike GHRP-6)
- ›Synergy with GHRH analogs
Primary Research Areas
- ›GH secretion
- ›Body composition
- ›Bone density
- ›Age-related GH decline
- ›Selective secretagogue research
Key Research Findings
- Stimulated GH release comparable to GHRP-6 without cortisol or prolactin elevation
- Demonstrated dose-dependent GH release with a wider therapeutic window
- Synergistic GH amplification when combined with CJC-1295
Research Overview
A selective growth hormone secretagogue that stimulates GH release via the ghrelin/GHSR-1a receptor without significantly affecting cortisol, ACTH, or prolactin levels. This selectivity distinguishes it from other GHRPs like GHRP-6 and hexarelin.
Origin: Synthetic pentapeptide GH secretagogue developed by Novo Nordisk
Mechanism of Action
- GHSR-1a (ghrelin receptor) agonism
- Selective GH pulse amplification
- Minimal cortisol/prolactin elevation
- No appetite stimulation (unlike GHRP-6)
- Synergy with GHRH analogs
Primary Research Areas
- GH secretion
- Body composition
- Bone density
- Age-related GH decline
- Selective secretagogue research
Key Published Findings
- Stimulated GH release comparable to GHRP-6 without cortisol or prolactin elevation
- Demonstrated dose-dependent GH release with a wider therapeutic window
- Synergistic GH amplification when combined with CJC-1295
Research Protocol
Commonly studied routes: Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized, 2-8°C reconstituted
Important Notice
Ipamorelin (5mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Specifiche di ricerca
Synthesized for strict analytical consistency. Verified via HPLC/MS.Vedi standard qualità →
Manipolazione e conservazione
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water